Jones Financial Companies
COGT icon

Jones Financial Companies’s Cogent Biosciences COGT Stock Holding History

Jones Financial Companies’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$585K Buy
15,360
+528
+4% +$18.5K ﹤0.01% 2154
2026
Q1 		$535K Buy
14,832
+14,565
+5,455% +$538K ﹤0.01% 2006
2025
Q4 		$9.48K Buy
+267
New +$7.51K ﹤0.01% 3242

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jones Financial Companies's COGT Position: Q2 2026 in Review

Jones Financial Companies increased its Cogent Biosciences (COGT) stake by 3.6% in Q2 2026, buying an estimated $18.5K and bringing the position to 15,360 shares worth $585K. The position accounts for ﹤0.01% of the portfolio, ranked #2154.

Jones Financial Companies first reported a position in COGT in Q4 2025 and has held it in 3 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Jones Financial Companies held 15,360 shares of Cogent Biosciences worth $585K as of Q2 2026.
  • Jones Financial Companies bought 528 Cogent Biosciences shares in Q2 2026, an estimated $18.5K.
  • Cogent Biosciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2154 holding.
  • Jones Financial Companies first reported a position in Cogent Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.